Hepatic mass lesions
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18-65 years, no gender requirement; BMI 18-28 kg/m2 2. Elective surgical patients with ASA grade I-II; 3. The level of transaminase is less than 2.5 times the normal value; Child-Pugh grade A.
Exclusion criteria
Exclusion criteria: 1. Those with a history of radiotherapy and chemotherapy, hormone therapy, and immune adjuvant therapy; 2. Thrombosis, bile duct obstruction of portal vein or hepatic artery thrombosis; 3. Patients with severe heart, kidney (serum creatinine > 2 mg/dl) and endocrine diseases or immune system diseases before operation; 4. Patients with adrenal insufficiency before operation; 5. Long-term use of sedative and analgesic drugs; 6. History of allergy to anesthetics; 7. Those with a history of mental illness; 8. Chronic alcoholics or recent history of heavy drinking.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alanine aminotransferase;Aspartate aminotransferase;Total bilirubin;Prothrombin time;Activated partial thromboplastin time, APTT;Interleukin-2, IL-2;Interleukin-6, IL-6;Gamma interferon, IFN-?;NK cell, ZLK-CD16+CD56+;T lymphocytes, ZLK-CD4+/CD8+; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure;Heart rate, HR;L-?-glutamyl transpeptidase, GGT;PT Internationalized Normalized Ratio, PT-INR;Thrombin time, TT;Fibrinogen, FIB;Interleukin-8, IL-8;Tumor necrosis factor alpha, TNF-a; | — |
Countries
China
Contacts
The First Affiliated Hospital of Nanjing Medical University